Keyword search
Filter results by
Search HelpKeyword(s)
Subject
Survey or statistical program
Results
All (7)
All (7) ((7 results))
- Articles and reports: 88F0006X2007006Description:
This descriptive working paper provides highlights from the Biotechnology Use and Development Survey 2005. Data on innovative biotechnology firms are presented by region, sectors and firm size. The data include firm revenues, R&D activities, human resources, firm financing, age of firms, country of control and the proportion of publicly traded firms.
Release date: 2007-12-05 - 2. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - 3. Biotechnology use and development ArchivedArticles and reports: 88-003-X20050017771Geography: CanadaDescription:
Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.
Release date: 2005-02-09 - Articles and reports: 88-003-X20040026930Geography: CanadaDescription:
Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.
Release date: 2004-06-30 - 5. Coming of age - biotech revenues are on the rise ArchivedArticles and reports: 88-003-X20030016476Geography: CanadaDescription:
Canadian biotechnology is gaining momentum. More firms are getting their products onto the markets and increasing revenues. With the human health sector leading the way, biotechnology revenues rose by a massive 343% for the 1997 to 2001 period, reaching $3.5 billion in 2001. During this same period, the number of firms increased by 33%.
Release date: 2003-02-18 - 6. Canadian Biotechnology Industrial Activities: Features from the 1997 Biotechnology Survey ArchivedArticles and reports: 88F0006X2001012Description:
As of 1997, Canadian biotech industry was made of 282 core firms. Of these, 214 were small firms with less than 50 employees, 37 were medium firms with 51 to 150 employees, and 31 were large firms with over 150 employees. They earned $813 million from biotech products sales, $311 million of which were from exports. They employed 9,000 people in biotech related activities and had 8,924 products at all stages of development. Private placements, venture capital and labour sponsored funds were these firms main sources of financing capital. Access to capital was the most serious obstacle faced by the biotech firms in 1997. Marketing and distribution were their major reasons for entertaining strategic alliances, while universities were their most preferred R&D partners.
Release date: 2001-09-25 - Articles and reports: 88-003-X20010025752Geography: CanadaDescription:
With revenues of almost $2 billion, what are the characteristics and activities of firms that use or develop biotechnology as an important part of their firm's activities? Human Health biotechnology dominates both the revenue and spending in the biotechnology sector. Read this enlightening article for further details including dicussion on the geographic location and size of Canadian biotechnology firms.
Release date: 2001-05-02
Data (0)
Data (0) (0 results)
No content available at this time.
Analysis (7)
Analysis (7) ((7 results))
- Articles and reports: 88F0006X2007006Description:
This descriptive working paper provides highlights from the Biotechnology Use and Development Survey 2005. Data on innovative biotechnology firms are presented by region, sectors and firm size. The data include firm revenues, R&D activities, human resources, firm financing, age of firms, country of control and the proportion of publicly traded firms.
Release date: 2007-12-05 - 2. Canadian biotechnology activity, 2003 ArchivedArticles and reports: 88-003-X20050028021Geography: CanadaDescription:
Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.
Release date: 2005-06-20 - 3. Biotechnology use and development ArchivedArticles and reports: 88-003-X20050017771Geography: CanadaDescription:
Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.
Release date: 2005-02-09 - Articles and reports: 88-003-X20040026930Geography: CanadaDescription:
Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.
Release date: 2004-06-30 - 5. Coming of age - biotech revenues are on the rise ArchivedArticles and reports: 88-003-X20030016476Geography: CanadaDescription:
Canadian biotechnology is gaining momentum. More firms are getting their products onto the markets and increasing revenues. With the human health sector leading the way, biotechnology revenues rose by a massive 343% for the 1997 to 2001 period, reaching $3.5 billion in 2001. During this same period, the number of firms increased by 33%.
Release date: 2003-02-18 - 6. Canadian Biotechnology Industrial Activities: Features from the 1997 Biotechnology Survey ArchivedArticles and reports: 88F0006X2001012Description:
As of 1997, Canadian biotech industry was made of 282 core firms. Of these, 214 were small firms with less than 50 employees, 37 were medium firms with 51 to 150 employees, and 31 were large firms with over 150 employees. They earned $813 million from biotech products sales, $311 million of which were from exports. They employed 9,000 people in biotech related activities and had 8,924 products at all stages of development. Private placements, venture capital and labour sponsored funds were these firms main sources of financing capital. Access to capital was the most serious obstacle faced by the biotech firms in 1997. Marketing and distribution were their major reasons for entertaining strategic alliances, while universities were their most preferred R&D partners.
Release date: 2001-09-25 - Articles and reports: 88-003-X20010025752Geography: CanadaDescription:
With revenues of almost $2 billion, what are the characteristics and activities of firms that use or develop biotechnology as an important part of their firm's activities? Human Health biotechnology dominates both the revenue and spending in the biotechnology sector. Read this enlightening article for further details including dicussion on the geographic location and size of Canadian biotechnology firms.
Release date: 2001-05-02
Reference (0)
Reference (0) (0 results)
No content available at this time.
- Date modified: